126 related articles for article (PubMed ID: 17696834)
41. Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience.
Sakamoto A
Endocr Pathol; 2004; 15(4):307-11. PubMed ID: 15681854
[TBL] [Abstract][Full Text] [Related]
42. [Anatomo-pathology and histological prognosis of follicular thyroid carcinoma].
de Micco C
Ann Endocrinol (Paris); 1997; 58(3):172-82. PubMed ID: 9239238
[TBL] [Abstract][Full Text] [Related]
43. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
44. [Expression of protein p53: the marker of low neoplastic cell differentiation in thyroid carcinoma].
Szybiński P; Nowak W; Stachura J; Nowak K; Przybylik-Mazurek E; Buziak-Bereza M
Wiad Lek; 2001; 54 Suppl 1():88-94. PubMed ID: 12182067
[TBL] [Abstract][Full Text] [Related]
45. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
46. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid.
Volante M; Cavallo GP; Papotti M
Endocr Pathol; 2004; 15(4):313-7. PubMed ID: 15681855
[TBL] [Abstract][Full Text] [Related]
48. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma.
Piana S; Frasoldati A; Di Felice E; Gardini G; Tallini G; Rosai J
Am J Surg Pathol; 2010 Jun; 34(6):868-72. PubMed ID: 20463572
[TBL] [Abstract][Full Text] [Related]
49. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
Zaydfudim V; Feurer ID; Griffin MR; Phay JE
Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
[TBL] [Abstract][Full Text] [Related]
50. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
51. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
52. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
Hughes CJ; Shaha AR; Shah JP; Loree TR
Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
[TBL] [Abstract][Full Text] [Related]
53. Cause of death in patients with well-differentiated thyroid carcinoma.
Beasley NJ; Walfish PG; Witterick I; Freeman JL
Laryngoscope; 2001 Jun; 111(6):989-91. PubMed ID: 11404609
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors in patients with differentiated thyroid carcinoma.
Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
[TBL] [Abstract][Full Text] [Related]
55. [The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
Böttger T; Potratz D; Schernus B; Klupp J; Stöckle M; Junginger T
Chirurg; 1994 Mar; 65(3):190-3. PubMed ID: 8194403
[TBL] [Abstract][Full Text] [Related]
56. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
[TBL] [Abstract][Full Text] [Related]
57. Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination.
Ito Y; Hirokawa M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2007 Jul; 31(7):1417-24. PubMed ID: 17534542
[TBL] [Abstract][Full Text] [Related]
58. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.
Pilotti S; Collini P; Mariani L; Placucci M; Bongarzone I; Vigneri P; Cipriani S; Falcetta F; Miceli R; Pierotti MA; Rilke F
Am J Surg Pathol; 1997 Dec; 21(12):1466-73. PubMed ID: 9414190
[TBL] [Abstract][Full Text] [Related]
59. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
Jin M; Kim ES; Kim BH; Kim HK; Yi HS; Jeon MJ; Kim TY; Kang HC; Kim WB; Shong YK; Kim M; Kim WG
Endocrinol Metab (Seoul); 2020 Sep; 35(3):618-627. PubMed ID: 32981304
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid.
Shaha AR; Loree TR; Shah JP
Surgery; 1995 Dec; 118(6):1131-6; discussion 1136-8. PubMed ID: 7491533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
